All the above observations prompted us to investigate, in a panel of NSCLC cell lines with different levels of HER-2 expression or carrying HER-2 mutation, the effect of T-DM1 on cell proliferation and survival. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.